Publication:
Tumor necrosis factor-alpha inhibitors for the treatment of psoriasis patients with liver cirrhosis: A report of four cases with a literature review

Simple item page
dc.contributor.authorSALMAN, ANDAƇ
dc.contributor.authorsErgun, Tulin; Seckin-Gencosmanoglu, Dilek; Salman, Andac; Qzgen, Zuleyha; Ocak, Esra Sarac; Avsar, Erol; Imeryuz, Nese
dc.date.accessioned2022-03-14T08:27:20Z
dc.date.available2022-03-14T08:27:20Z
dc.date.issued2017
dc.description.abstractPatients with psoriasis are at an increased risk of developing liver disease due to various factors. The existing data regarding the treatment of psoriasis patients with associated liver cirrhosis is limited. We report four patients of psoriasis with liver cirrhosis who were treated with TNF-alpha inhibitors for a mean duration of 35.4 months. Two patients were treated with etanercept, one with adalimumab and one was treated with both infliximab and etanercept. Three patients tolerated the treatment well without any deterioration of liver disease whereas one died of progressive liver disease. Although large-scale, controlled studies are needed, this case series provides insights regarding the long-term safety of TNF-alpha inhibitors in patients with psoriasis and liver cirrhosis.
dc.identifier.doi10.4103/0378-6323.186498
dc.identifier.eissn0973-3922
dc.identifier.issn0378-6323
dc.identifier.pubmed27451931
dc.identifier.urihttps://hdl.handle.net/11424/241812
dc.identifier.wosWOS:000398077700010
dc.language.isoeng
dc.publisherMEDKNOW PUBLICATIONS & MEDIA PVT LTD
dc.relation.ispartofINDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAdalimumab
dc.subjectcirrhosis
dc.subjectetanercept
dc.subjectinfliximab
dc.subjectpsoriasis
dc.subjectTNF-alpha inhibitors
dc.subjectCHRONIC HEPATITIS-C
dc.subjectPRIMARY BILIARY-CIRRHOSIS
dc.subjectRHEUMATOID-ARTHRITIS
dc.subjectETANERCEPT
dc.subjectTHERAPY
dc.subjectANTAGONISTS
dc.subjectDISEASE
dc.subjectGUIDELINES
dc.subjectINFECTION
dc.subjectFIBROSIS
dc.titleTumor necrosis factor-alpha inhibitors for the treatment of psoriasis patients with liver cirrhosis: A report of four cases with a literature review
dc.typearticle
dspace.entity.typePublication
local.avesis.id5e323e91-4c57-43c7-be6f-f80bfd32fd2e
local.import.packageSS16
local.indexed.atWOS
local.indexed.atSCOPUS
local.indexed.atPUBMED
local.journal.numberofpages5
local.journal.quartileQ2
oaire.citation.endPage59
oaire.citation.issue1
oaire.citation.startPage55
oaire.citation.titleINDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY
oaire.citation.volume83
relation.isAuthorOfPublication22ba329a-4b06-4eb1-8549-b8b32f2d766b
relation.isAuthorOfPublication.latestForDiscovery22ba329a-4b06-4eb1-8549-b8b32f2d766b

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Tumor necrosis factor-alpha inhibitors for the treatment of psoriasis patients with liver cirrhosis_ A report of four cases with a literature review.pdf
Size:
280.63 KB
Format:
Adobe Portable Document Format
Download

Collections

Research Outputs